Drug companies are racing to catch up to Eli Lilly and Novo Nordisk, seeking to require fewer shots or reduce side effects.

The Medicare GLP-1 Bridge may hold the key to Eli Lilly's market share.

Wondering why your GLP-1 medication isn't working? Discover the most common reasons weight loss stalls on Ozempic, Wegovy, ...

Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant professor at the ...

A $350 genetic test developed by researchers at Mayo Clinic in Rochester, Minn., and subsequently licensed to Phenomic Sciences, seeks to assign risk scores to patients regarding their likelihood of ...

Samsung has teamed up with diabetes experts at Massachusetts General Hospital to see how Galaxy Watch 8 can help prevent muscle loss in GLP-1 patients.

Early data regarding the use of GLP-1 medications like Ozempic and Wegovy to treat addiction is “very, very, exciting,” Nora Volkow, the director of the National Institute on Drug Abuse, said Thursday ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...

Penn Holderness, a family influencer, has the highest genetic risk for Alzheimer's. He started taking a GLP-1 solely to ...

Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most ...